Allecra Therapeutics Submits New Drug Application to the U.S. FDA for Exblifep for the Treatment of Complicated Urinary Tract Infections

SAINT-LOUIS, France& WEIL AM RHEIN, Germany June 27, 2023 --(BUSINESS WIRE)--Allecra Therapeutics (“Allecra”) announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news